Clinical Trials Sponsored by Alvotech Swiss AG

Total 63 results

Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

New Zealand
Alvotech Swiss AG

Completed

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Estonia, Ukraine
Alvotech Swiss AG

Active, not recruiting

AVT03 With Xgeva in Healthy Male Subjects

This is a Phase Study Conducted in Healthy Volunteers

South Africa
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE)

Neovascular (Wet) AMD

Slovakia, Czechia, Georgia, Japan, Latvia
Alvotech Swiss AG

Completed

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Psoriasis

Georgia, Estonia, Poland, Ukraine
Alvotech Swiss AG

Completed

Auto-injector Real Life Handling in Patients

RA

Georgia, Ukraine
Alvotech Swiss AG

Completed

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

Phase 1

New Zealand
Alvotech Swiss AG

Completed

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (ALVOPAD)

Healthy Volunteers

Australia
Alvotech Swiss AG

Active, not recruiting

Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND (ALVOBOND)

Osteoporosis, Postmenopausal

South Africa
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease (ALVOEYE-D)

Chorioretinal Vascular Disease

Georgia
Alvotech Swiss AG

Active, not recruiting

Comparative, Multicenter Study in Subjects With Rheumatoid Arthritis, ALVOFLEX (ALVOFLEX)

Rheumatoid Arthritis

Bulgaria
Alvotech Swiss AG

Completed

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Iceland, Russian Federation, Ukraine
Alvotech Swiss AG

Completed

Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

Healthy Volunteers

New Zealand, Australia
Alvotech Swiss AG
Iqvia Pty Ltd

Completed

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

Healthy Adult Subjects

New Zealand, United Kingdom
Alvotech Swiss AG
Iqvia Pty Ltd

Completed

Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)

Psoriasis

Australia, New Zealand
Swiss Medical Food AG
iOMEDICO AG

Completed

Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy (STEFANO)

CIPN in Adjuvant Colon Cancer Patients | CIPN in Adjuvant Breast Cancer Patients

Germany
Swiss Cardio Technologies AG

Completed

Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™

Valve Surgery | Coronary Artery Bypass Surgery

Germany, Austria
Vital Solutions Swiss AG

Completed

Investigation of the Influence of Careless™, a Mangifera Indica Fruit Powder, on Microcirculation and Endothelial Function

Cardiovascular Disease | Metabolism | Microcirculation

Germany
Vital Solutions Swiss AG

Completed

Investigation of Long-term Effects of CarelessTM on Microcirculation

Metabolic Disease | Disorder of Circulatory System

Germany
Resistell AG
Innosuisse - Swiss Innovation Agency

Completed

Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis (NANO-RAST)

Bacteremia Sepsis

Switzerland
Swiss Federal Institute of Technology
Auxivo AG

Completed

Evaluation of a Soft Exoskeleton to Support Forward Leaning and Lifting

Occupational Exposure

Switzerland
OnkoZentrum Zürich AG
Stiftung Swiss Tumor Institute

Terminated

Efficacy of the "Consilium" Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients (APP-2)

Telemedicine | eHealth

Switzerland, Austria, Germany
Swiss Federal Institute of Technology
Mibelle AG

Completed

Iron Isotope Study of an Iron Fatty Acid Complex (IFAC)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology
Rehaklinik Zihlschlacht AG

Completed

Strategies of Therapy With the Exoskeleton Robot ARMin (MultiVIT-ARMin)

Stroke

Switzerland
Cereneo AG
University of Zurich; Swiss Federal Institute of Technology; Swiss Commission... and other collaborators

Terminated

Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System (LOKOMAT)

Post Stroke Gait Training

Switzerland
Swiss Federal Institute of Technology
Rehaklinik Zihlschlacht AG

Recruiting

Usability of a Novel Cueing Device for Patients With Parkinson's Disease (TCP)

Parkinson Disease | Freezing of Gait

Switzerland
Sonova AG
Swiss Commission for Technology and Innovation

Completed

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 3 (HEAR3D_CE3)

Ability, Spatial

Switzerland
Sonova AG
Swiss Commission for Technology and Innovation

Completed

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 2 (HEAR3D_CE2)

Ability, Spatial

Switzerland
Sonova AG
Swiss Commission for Technology and Innovation

Completed

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments

Ability, Spatial

Switzerland
Anbics Management-Services Ag
Swiss National Science Foundation

Terminated

Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia

Pneumonia, Ventilator-Associated | Pseudomonas Infections

Belgium, Former Serbia and Montenegro, France, Poland, Spain, Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss Cancer League

Not yet recruiting

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer (Ablatio)

Bile Duct Cancer

Switzerland
University Hospital, Basel, Switzerland
Sanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer League

Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (GEMOXEL)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Recruiting

Concentration Impact Nicotine Salt (CINS)

Smoking Cessation | Vaping

Switzerland
Bacoba AG
University Hospital, Basel, Switzerland; Swiss TPH, Basel, Switzerland

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses

Healthy

Switzerland
Manuela Eicher
Swiss Cancer League; Lindenhofgruppe AG

Completed

Testing of the Cancer Thriving and Surviving Breast Cancer Program (COSS)

Breast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast Cancer

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Recruiting

Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control (ParOP)

Pain

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Completed

Digitalized Differential Diagnosis Broadening in Emergency Rooms (DDX-BRO)

Emergencies | Diagnoses Disease

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Completed

Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function (SERVE)

Heart Defects, Congenital | Transposition of Great Vessels With Ventricular Inversion

Switzerland, Austria
Swiss Federal Institute of Technology
Zuercher Hoehenklinik Wald; Hocoma AG, Switzerland

Completed

ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization (ERIGO®LIFE)

Stroke | Spinal Cord Injury

Switzerland
University Hospital Inselspital, Berne
Tofwerk AG, Thun Switzerland (equipment, data analysis); Lungenliga Bern (main... and other collaborators

Completed

Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit

Lung Cancer | Lung Injury

Switzerland
Swiss Group for Clinical Cancer Research
Cantonal Hospital of St. Gallen; ProteoMediX AG

Active, not recruiting

Prostate Cancer Biobank

Prostatic Neoplasms

Switzerland
Peripal AG
University Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...

Completed

Human Factors Validation Testing for the Peripal System; a Manual Connection Assist Device for Peritoneal Dialysis Devices

Renal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on Dialysis

United Kingdom
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Recruiting

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma (MACOCUC-01)

Advanced Urothelial Carcinoma

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Completed

The PROAKTIV Study

Palliative Care

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Active, not recruiting

Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease (DIFU)

Diabetic Foot Ulcer

Switzerland
University of St.Gallen
Swiss National Science Foundation; University hospital of Bern; Sanitas Management...

Completed

The Effect of an Application-based Health Intervention (FoodCoach) on Food Purchases in Switzerland

Adult

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; Hôpital Fribourgeois; Kantonsspital Baden

Recruiting

An INtervention TO Improve MOBility of Older Hospitalized Patients (INTOMOB)

Iatrogenic Disease | Sarcopenia | Hospital Mobility | Mobility Limitation | Life-Space | Functional Status | Hospital-Acquired Condition | Muscle Atrophy or Weakness

Switzerland
University of Zurich
Swiss Federal Institute of Technology in Zurich (ETH Zurich); Tyromotion AG

Completed

Encouragement-induced Movement Therapy in Daily Life (ISEAR)

Stroke

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern; Fachhochschule Nordwestschweiz

Recruiting

STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room (StOP?)

Communication Research | Communication, Multidisciplinary

Switzerland
University Hospital, Basel, Switzerland
University Hospital, Geneva; Swiss National Science Foundation; Swiss Heart Foundation and other collaborators

Completed

Health Consequences of the Burden of Atrial Fibrillation (SwissAF-BURDEN)

Atrial Fibrillation | Burden

Switzerland

Clinical Trials Sponsored by Alvotech Swiss AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations